Survival estimates
| . | Total trial cohort (n = 39) . | Low risk (n = 16) . | High risk (n = 23) . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| No. of events . | 1 y . | 2 y . | No. of events . | 1 y . | 2 y . | No. of events . | 1 y . | 2 y . | |
| PFS | 18 | 63% (50-81) | 58% (44-76) | 6 | 75% (57-100) | 69% (49-96) | 9 | 63% (45-87) | 63% (45-87) |
| PFS post-IR | 15 | 71% (57-87) | 65% (52-82) | — | — | ||||
| EFS | 19 | 61% (47-78) | 55% (41-74) | 7 | 69% (49-96) | 63% (43-91) | 10 | 58% (40-83) | 58% (40-83) |
| OS | 10 | 81% (70-95) | 76% (63-91) | 2 | 88% (73-100) | 88% (73-100) | 8 | 72% (55-94) | 67% (50-90) |
| . | Total trial cohort (n = 39) . | Low risk (n = 16) . | High risk (n = 23) . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| No. of events . | 1 y . | 2 y . | No. of events . | 1 y . | 2 y . | No. of events . | 1 y . | 2 y . | |
| PFS | 18 | 63% (50-81) | 58% (44-76) | 6 | 75% (57-100) | 69% (49-96) | 9 | 63% (45-87) | 63% (45-87) |
| PFS post-IR | 15 | 71% (57-87) | 65% (52-82) | — | — | ||||
| EFS | 19 | 61% (47-78) | 55% (41-74) | 7 | 69% (49-96) | 63% (43-91) | 10 | 58% (40-83) | 58% (40-83) |
| OS | 10 | 81% (70-95) | 76% (63-91) | 2 | 88% (73-100) | 88% (73-100) | 8 | 72% (55-94) | 67% (50-90) |
Data are survival estimate (95% CI).
Risk stratified survival times are calculated from the date of interim assessment.